Semaglutide in obesity care: comprehensive evidence and emerging science

Chair: Jaime Almandoz (USA)

18:00 – 18:10Opening the conversation on modern obesity treatmentsJaime Almandoz (USA)
18:10 – 18:35Oral and injectable semaglutide: weight loss across formulationsSean Wharton (CAN)
18:35 – 19:00From weight loss to health gain: the broader benefits of semaglutideBarbara McGowan (GBR)
19:00 – 19:10Where evidence meets clinical practiceAll Faculty
19:10 – 19:25The next frontier: exploring amylin and complementary pathwaysLiana Billings (USA)
19:25 – 19:30The conversation continuesJaime Almandoz (USA)